Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice.

CONCLUSIONS: These results demonstrated that UAD could ameliorate STZ-induced bone deterioration through improving adipocyte dysfunction and enhancing new bone formation and inhibiting absorptive function of osteoclast in the bone of diabetic mice. PMID: 26097549 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26097549?dopt=Abstract

Source: International Journal of Clinical and Experimental Pathology - June 26, 2015 Category: Pathology Authors: Yu SG, Zhang CJ, Xu XE, Sun JH, Zhang L, Yu PF Tags: Int J Clin Exp Pathol Source Type: research